// App-Quantinova.ai

P4-10-03 : The genomic landscape of male breast cancers using the oncomine comprehensive assay for actionable mutations

Researchers

Presenter

  • Jane Bayani

Principal Investigators

  • Cheryl Crozier

  • Quang M Trinh

  • Megan Hopkins

  • Aime Lambert Uwimana

  • Tammy Piper

  • Carrie Cunningham

  • Monika Sobol

  • Stefan Aebi

  • Kim Benstead

  • Oliver Bogler

  • Lissandra Dal Lago

  • Florentine Hilbers

  • Ingrid Hedenfalk

  • Larissa Korde

  • Barbro Linderholm

  • John Martens

  • Lavinia Middleton

  • Melissa Murray

  • Catherine Kelly

  • Cecilia Nilsson

  • Monika Nowaczyk

  • Stephanie Peeters

  • Aleksandra Peric

  • Peggy Porter

  • Carolien Schrder

  • Isabel T Rubio

  • Kathryn J Ruddy

  • Christi van Asperen

  • Danielle Van Den Weyngaert

  • Carolien HM van Deurzen

  • Elise van Leeuwen-Stok

  • Joanna Vermeij

  • Eric Winer

  • Lincoln D Stein

  • Sharon H Giordano

  • Fatima Cardoso

  • John MS Bartlett

Medical Centers

  • Ontario Institute for Cancer Research, Toronto, ON, Canada

  • an Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium

  • Swiss Group for Clinical Cancer Research SAKK, Berne, Switzerland

  • Cheltenham General Hospital, United Kingdom

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Jules Bordet Institute, Bruxelles, Belgium

  • Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

  • Lund University Hospital, Lund, Sweden

  • University of Washington, Seattle, WA

  • Sahlgrenska University Hospital, Gothenburg, Sweden

  • Erasmus University Medical Center, Rotterdam, Netherlands

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • All-Ireland Co-operative Oncology Research Group (ICORG), Dublin, Ireland

  • Västmanlands Hospital, VästerÃ¥s, Sweden

  • Specialist Hospital. St. Wojciech, Gdansk, Poland

  • Department of Oncology & Radiotherapy, UZ Leuven, Leuven, Belgium

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • Universitair Medisch Centrum Groningen, Groningen, Netherlands

  • Hospital Universitario del Mar, Barcelona, Spain

  • Mayo Clinic, Rochester, MN

  • Leiden University Medical Centre, Leiden, Netherlands

  • ZNA Middelheim, Middelheim, Belgium

  • Dutch Breast Cancer Research Group (BOOG), Amsterdam, Noord-Holland, Netherlands

  • Department of Medical Oncology, ZNA, Jan Palfijn, Belgium

  • Dana-Farber Cancer Institute, Boston, MA

  • Champalimaud Clinical Center/Champalimaud Foundation, Breast Unit, Lisbon, Portugal

Locations

  • Canada

  • Belgium

  • United Kingdom

  • Swaziland

  • United States

  • Sweden

  • Netherlands

  • Ireland

  • Poland

  • Spain

  • Portugal

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • NCT02465060

Sponsors

  • Breast Cancer Research Foundation (BCRF)

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved